Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

We present the Patient Annual Report in 2011 and the Treatment Annual Report in 2005 that were collected and analyzed by the Japan Society of Obstetrics and Gynecology. Data on 15 698 patients with cervical cancer, 7713 with endometrial cancer and 4672 with ovarian cancer in whom treatment was started in 2011 and data on the prognosis of 2985 patients with cervical cancer, 2812 with endometrial cancer, and 1839 with ovarian cancer who were started on treatment in 2005 were analyzed and summarized. Patient Annual Report in 2011: Stage 0 accounted for 58%, stage I for 24%, stage II for 9%, stage III for 5%, and stage IV for 4% of all the patients with cervical cancer. Stage 0 accounted for 6%, stage I for 61%, stage II for 8%, stage III for 18%, and stage IV for 7% of patients with endometrial cancer. Stage I accounted for 43%, stage II for 9%, stage III for 29%, and stage IV for 8% of patients with ovarian cancer. Treatment Annual Report in 2005: The 5-year overall survival rates of patients with cervical cancer were 91% in stage I, 78% in stage II, 57% in stage III, and 30% in stage IV. The 5-year overall survival rates of patients with endometrial cancer were 95% in stage I, 89% in stage II, 77% in stage III, and 23% in stage IV. The 5-year overall survival rates of patients with ovarian surface epithelialstromal tumors were 92% in stage I, 75% in stage II, 50% in stage III and 39% in stage IV.

Original languageEnglish
Pages (from-to)338-348
Number of pages11
JournalJournal of Obstetrics and Gynaecology Research
Volume40
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Annual Reports
Gynecology
Obstetrics
Japan
Endometrial Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms
Survival Rate
Therapeutics

Keywords

  • Annual report
  • Cervical cancer
  • Endometrial cancer
  • Gynecological cancer
  • Japan
  • Ovarian cancer

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Medicine(all)

Cite this

@article{b4570a8ee88a4b59a250013bfc75160d,
title = "Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013",
abstract = "We present the Patient Annual Report in 2011 and the Treatment Annual Report in 2005 that were collected and analyzed by the Japan Society of Obstetrics and Gynecology. Data on 15 698 patients with cervical cancer, 7713 with endometrial cancer and 4672 with ovarian cancer in whom treatment was started in 2011 and data on the prognosis of 2985 patients with cervical cancer, 2812 with endometrial cancer, and 1839 with ovarian cancer who were started on treatment in 2005 were analyzed and summarized. Patient Annual Report in 2011: Stage 0 accounted for 58{\%}, stage I for 24{\%}, stage II for 9{\%}, stage III for 5{\%}, and stage IV for 4{\%} of all the patients with cervical cancer. Stage 0 accounted for 6{\%}, stage I for 61{\%}, stage II for 8{\%}, stage III for 18{\%}, and stage IV for 7{\%} of patients with endometrial cancer. Stage I accounted for 43{\%}, stage II for 9{\%}, stage III for 29{\%}, and stage IV for 8{\%} of patients with ovarian cancer. Treatment Annual Report in 2005: The 5-year overall survival rates of patients with cervical cancer were 91{\%} in stage I, 78{\%} in stage II, 57{\%} in stage III, and 30{\%} in stage IV. The 5-year overall survival rates of patients with endometrial cancer were 95{\%} in stage I, 89{\%} in stage II, 77{\%} in stage III, and 23{\%} in stage IV. The 5-year overall survival rates of patients with ovarian surface epithelialstromal tumors were 92{\%} in stage I, 75{\%} in stage II, 50{\%} in stage III and 39{\%} in stage IV.",
keywords = "Annual report, Cervical cancer, Endometrial cancer, Gynecological cancer, Japan, Ovarian cancer",
author = "Daisuke Aoki",
year = "2014",
doi = "10.1111/jog.12360",
language = "English",
volume = "40",
pages = "338--348",
journal = "Asia-Oceania Journal of Obstetrics and Gynaecology",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",
number = "2",

}

TY - JOUR

T1 - Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013

AU - Aoki, Daisuke

PY - 2014

Y1 - 2014

N2 - We present the Patient Annual Report in 2011 and the Treatment Annual Report in 2005 that were collected and analyzed by the Japan Society of Obstetrics and Gynecology. Data on 15 698 patients with cervical cancer, 7713 with endometrial cancer and 4672 with ovarian cancer in whom treatment was started in 2011 and data on the prognosis of 2985 patients with cervical cancer, 2812 with endometrial cancer, and 1839 with ovarian cancer who were started on treatment in 2005 were analyzed and summarized. Patient Annual Report in 2011: Stage 0 accounted for 58%, stage I for 24%, stage II for 9%, stage III for 5%, and stage IV for 4% of all the patients with cervical cancer. Stage 0 accounted for 6%, stage I for 61%, stage II for 8%, stage III for 18%, and stage IV for 7% of patients with endometrial cancer. Stage I accounted for 43%, stage II for 9%, stage III for 29%, and stage IV for 8% of patients with ovarian cancer. Treatment Annual Report in 2005: The 5-year overall survival rates of patients with cervical cancer were 91% in stage I, 78% in stage II, 57% in stage III, and 30% in stage IV. The 5-year overall survival rates of patients with endometrial cancer were 95% in stage I, 89% in stage II, 77% in stage III, and 23% in stage IV. The 5-year overall survival rates of patients with ovarian surface epithelialstromal tumors were 92% in stage I, 75% in stage II, 50% in stage III and 39% in stage IV.

AB - We present the Patient Annual Report in 2011 and the Treatment Annual Report in 2005 that were collected and analyzed by the Japan Society of Obstetrics and Gynecology. Data on 15 698 patients with cervical cancer, 7713 with endometrial cancer and 4672 with ovarian cancer in whom treatment was started in 2011 and data on the prognosis of 2985 patients with cervical cancer, 2812 with endometrial cancer, and 1839 with ovarian cancer who were started on treatment in 2005 were analyzed and summarized. Patient Annual Report in 2011: Stage 0 accounted for 58%, stage I for 24%, stage II for 9%, stage III for 5%, and stage IV for 4% of all the patients with cervical cancer. Stage 0 accounted for 6%, stage I for 61%, stage II for 8%, stage III for 18%, and stage IV for 7% of patients with endometrial cancer. Stage I accounted for 43%, stage II for 9%, stage III for 29%, and stage IV for 8% of patients with ovarian cancer. Treatment Annual Report in 2005: The 5-year overall survival rates of patients with cervical cancer were 91% in stage I, 78% in stage II, 57% in stage III, and 30% in stage IV. The 5-year overall survival rates of patients with endometrial cancer were 95% in stage I, 89% in stage II, 77% in stage III, and 23% in stage IV. The 5-year overall survival rates of patients with ovarian surface epithelialstromal tumors were 92% in stage I, 75% in stage II, 50% in stage III and 39% in stage IV.

KW - Annual report

KW - Cervical cancer

KW - Endometrial cancer

KW - Gynecological cancer

KW - Japan

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=84898000764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898000764&partnerID=8YFLogxK

U2 - 10.1111/jog.12360

DO - 10.1111/jog.12360

M3 - Article

C2 - 24472052

AN - SCOPUS:84898000764

VL - 40

SP - 338

EP - 348

JO - Asia-Oceania Journal of Obstetrics and Gynaecology

JF - Asia-Oceania Journal of Obstetrics and Gynaecology

SN - 1341-8076

IS - 2

ER -